FridayOct 02, 2026 10:00 am

Blood Samples Could Be Used to Find Cancer-Specific Proteins Needed for Immunotherapy

Immunotherapy, a form of personalized cancer treatment, currently requires a tumor sample to be removed surgically and analyzed so that the personalized treatment needed by the patient can be manufactured. However, getting the needed tumor sample can be challenging in many patients, such as those with tumors in hard-to-access parts of the body or those whose physical condition makes it risky to have surgery done to extract a sample.  In some cases, the wait time to have a biopsy is long, which can delay the commencement of needed treatment. A new study suggests that a blood sample could provide a…

Continue Reading

TuesdaySep 29, 2026 10:30 am

Survey Shows Most American Adults Support Vaccination, But Uncertainty is Widespread

According to a new survey conducted by NFID (National Foundation for Infectious Diseases), the vast majority of American adults, 77%, support vaccines. However, there is widespread uncertainty regarding which specific vaccines people need.  The survey, which is conducted annually, sought to gather the views of the public across the country on matters of vaccination. The survey largely focused on vaccines designed for respiratory conditions, specifically flu, RSV (respiratory syncytial virus), pneumococcal disease, and Covid-19.  The survey results showed that while Americans hold positive views about vaccines, there is a gap in their clarity on the specific vaccines they need to…

Continue Reading

MondaySep 28, 2026 10:00 am

Researchers in South Korea Identify New Protein That Controls Brain Cancer Growth

Glioblastoma is the deadliest form of brain cancer due to its aggressive growth rate. Most patients don’t survive for more than a year after diagnosis, and the disease quickly develops resistance to existing treatments. Scientists have been racing to find ways to treat this malignancy and prolong patient survival.  Now, a team of researchers in South Korea have found a novel protein that acts as the switch regulating glioblastoma’s growth. The researchers also identified a compound that can turn off this switch, effectively slowing down the cancer’s growth and reducing the size of tumors.  Doctor Han Tae-su, who led the…

Continue Reading

TuesdaySep 22, 2026 10:00 am

Survey Finds That Insurance Doesn’t Shield Americans from Medical Debt

A nationwide survey conducted by the Commonwealth Fund has found that contrary to a common view that it is the uninsured that incur medical debt, the reality is that a sizeable fraction of adults in the U.S. with health insurance have medical debt.  The survey data reveals that about 33% of Americans that have private health insurance have medical debt, and nearly 40% of this group revealed that they drained part or all of their savings so they could pay bills. This finding offers a sobering reality check: health insurance is failing to deliver on one of its key objectives…

Continue Reading

FridaySep 18, 2026 10:00 am

Bacterial Strains Influence Meningitis, Pneumonia Risks from Air Pollution, New Study Finds

A new study has found that the risk of people developing sepsis, meningitis or pneumonia as a result of exposure to air pollution is influenced by the specific bacterial strains that an individual carries within their microbiome.  The study, whose findings were published in the journal Nature Microbiology on September 14 this year, was conducted by a joint team from the South African National Institute of Communicable Diseases, the Supercomputing Center in Barcelona, Spain, together with other collaborators.  The researchers focused on Streptococcus pneumoniae, a bacterium that lives within the respiratory microbiome. It typically lives inside the throat and nose,…

Continue Reading

ThursdaySep 17, 2026 10:00 am

Accelerated Biological Aging Could Explain Why Younger Adults are Getting Cancer

Scientists have been struggling to understand why more people who are less than 55 years of age are being diagnosed with cancer. These cases are described as early-onset cancer because cancers typically tend to develop in people above 55, but this is changing and researchers want to know why.  It was “understandable” when people were diagnosed with cancer at 55 years or beyond because as the body gets older, it accumulates damage at the cellular level to the extent that tumor development begins.  Now that younger people are developing cancer, the scientific community is racing to find out why, even…

Continue Reading

FridaySep 11, 2026 10:00 am

Rising Rates of the Uninsured Could Affect Every American

As more Americans become underinsured or uninsured as a result of rising health insurance premiums and the several changes that were passed in the Big Beautiful Act, the impacts of the rising numbers of the uninsured are likely to be felt by every American. Several healthcare professionals have sounded the alarm on this brewing issue.  The Congressional Budget Office estimates that by 2034, about 16 million Americans will be uninsured. One of the factors contributing to people becoming uninsured is the H.R. 1 requirement for people on Medicaid to reconfirm their address and work situation at six-month intervals in order to remain on Medicaid.  Safety net hospitals already operate on tight margins because…

Continue Reading

WednesdaySep 09, 2026 10:00 am

Expert Flags Hidden Crisis in the Way UTIs Are Diagnosed

For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to use the bathroom. For some, there is a sudden onset of discomfort that they just cannot ignore. While many receive a dose of antibiotics after being told what’s bothering them “is just a UTI,” several questions remain in the mind of the woman.  Was the sample used reliable? Did they receive the right diagnosis? Was the medical professional sure about what’s going on? These uncertainties put the issue beyond a medical one and expand it into a human issue as well.  Giovanna Forte, a health tech entrepreneur…

Continue Reading

ThursdaySep 03, 2026 10:00 am

Administering Immunotherapy Prior to Surgery Improves Brain Cancer Treatment Outcomes

A preclinical study conducted by a joint team from Switzerland has found that treatment outcomes for glioblastoma patients improved considerably if they received immunotherapy before undergoing surgery to remove the tumors, instead of first having the tumors surgically removed and then receiving immunotherapy.  The study findings appeared in the Nature Communications journal. The researchers are based at UNIGE (University of Geneva) and HUG (Geneva University Hospitals) and were led by Associate Professor Denis Migliorini, who works at UNIGE.  Only a tiny fraction (5%) of glioblastoma patients survive for five or more years even after receiving existing treatments that include surgery, chemotherapy and radiotherapy. The current practice is to surgically remove as much of the brain…

Continue Reading

FridayAug 28, 2026 10:00 am

New mRNA Platform May Expedite Delivery of Infectious Disease, Cancer Treatments

mRNA vaccines and therapies have had a profound effect on the way various diseases, including infectious diseases like Covid-19, are treated. Scientists are working to improve how these treatments can be leveraged even more, and a research team has made a discovery that could introduce an improved mRNA platform through which vaccines and other treatments for cancer, infectious diseases and autoimmune conditions can be delivered more efficiently using lower doses than has been the norm.  This new study was conducted by a joint team of scientists from Johns Hopkins Medicine, the National Cancer Institute, and Leidos Biomedical Research. The National Institutes of Health (NIH) funded the research.  For their…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000